Privia Health™, Oracle and the Department of Health and Human Services Collaborate on Community-Based Study of Coronavirus (COVID-19)

Est. Reading Time: 3 Minutes

Privia’s national network joins collaborative effort to study and treat Coronavirus

ARLINGTON, VA (May 15, 2020) In an effort to provide doctors and researchers with up-to-date information on the effectiveness of potential therapies to fight COVID-19 (Coronavirus), Privia Health is partnering with Oracle and the U.S. Department of Health and Human Services opens in a new window to conduct community-based research of the disease and its treatment.

The project utilizes Oracle’s “Therapeutic Learning System,” an online platform designed with security in mind and developed to gather comprehensive, real-time data from doctors and clinicians about how patients are responding to various Coronavirus treatment options. An additional resource, called the Patient Monitoring System, allows patients to provide daily health updates, enabling medical experts and government officials to better understand the pandemic and develop strategies to fight it.

“Our physicians and providers are honored to join this national collaborative initiative and continue supporting our fight against the Coronavirus,” said Keith Fernandez, MD, Privia Health’s Chief Clinical Officer. “I’m extremely grateful for our patients who are volunteering their information and giving us additional ‘ammunition’ in the war against the pandemic’s impact on people around the world.”

Privia Health includes a network of more than 2,500 providers caring for 2.6 Million patients in multiple states. Privia’s proprietary cloud-based technology platform, innovative approach to patient engagement and focus on physician-driven wellness help improve patient outcomes and create healthier communities.

Through an ongoing partnership with Javara, Inc., an Integrated Clinical Research Organization, Privia’s physicians can also invite their patients to participate in clinical trials designed to develop treatments, and a potential vaccine, for the Coronavirus.

“We’re excited to bring our integrated approach to this project which will provide policy-makers and healthcare workers with the information they desperately need,” said Jennifer Byrne, CEO of Javara, Inc. “And I’m confident that community partnerships such as this one will not only help to provide vital information for this pandemic, but will also serve as a model approach to clinical care and clinical research that will help lay the foundations to better mitigate the next one.”

###About Privia Health
Privia Health™ is a national physician organization that transforms the healthcare delivery experience for physicians and consumers. Utilizing a platform of talent, tools and highly enabling technology, Privia has a proven track record of developing and elevating physician groups to top tier performance. Their approach of meeting providers where they are on the value continuum and partnering with health plans, health systems, and employers to better align reimbursements to quality, outcomes and performance has proven to be successful and replicable across multiple geographies. This platform of top industry talent, physician leadership development, scalable systems and proprietary technology reduces unnecessary healthcare costs, achieves better outcomes, and improves the health of patients and well being of providers. For more information: www.priviahealth.com @PriviaHealth

About Javara
Javara is a Winston-Salem, N.C.-based Integrated Research Organization driven to change the clinical research experience and expand access to clinical trials – for both providers and patients. The Javara team includes seasoned clinical research leaders who have collectively led over 10,000 trials and engaged more than 200,000 people in clinical trials. More information about Javara is at http://javararesearch.com